Fibroheal Woundcare Pvt Ltd, a dynamic startup recognized under Startup India and Startup Karnataka, has recently achieved a significant milestone by securing funding to bolster its pioneering work in the field of advanced wound care management. Although the exact amount raised remains undisclosed, this infusion of capital is a vital step towards expanding the company's innovative product line that harnesses the remarkable biomaterial properties of silk proteins. With a stellar portfolio that includes recognition from the National Technology Award in the startup category and support from prestigious organizations like DBT, Government of India, and the Center for Cellular and Molecular Platforms (CCAMP), Fibroheal is dedicated to addressing the pressing healthcare needs associated with slow-healing and difficult-to-heal wounds.
This funding will enable Fibroheal to further develop its bio-modified silk proteins, aimed at creating advanced medical devices and products designed to facilitate effective wound care management. By focusing on non-healing, acute, and chronic wounds, the company aspires to be a comprehensive wound care provider, transforming the landscape of wound treatment through unique and meaningful scientific advancements. The company’s proprietary silk protein technology enhances scaffold formation and tissue regeneration, driving faster healing outcomes. As Fibroheal undertakes this transformative journey in the wound care space, it aims not only to revolutionize healing processes but also to capitalize on the economic multiplier potential of silk and silk proteins for the masses in India. With this new funding, Fibroheal is poised to make a substantial impact on the healthcare industry and improve the quality of life for countless patients.
